
Waters Corporation WAT
$ 453.45
-3.61%
Country |
|
IPO year |
1995 |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
59.5 M |
Market Cap[1] |
$ 27 B |
EBITDA (LTM) |
$ 562 M |
P/E (LTM) |
70.219554 |
P/S (LTM) |
7.0155 |
EPS (LTM) |
5.83 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 63.94 | -7.35 % | $ 2.99 B | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 7.98 | -11.53 % | $ 333 M | NYSE American | ||
|
IQVIA Holdings
IQV
|
$ 265.11 | 0.5 % | $ 45.6 B | NYSE,SPB | ||
|
Anixa Biosciences
ANIX
|
$ 3.01 | -8.23 % | $ 97.7 K | Nasdaq Capital Market | ||
|
Biodesix
BDSX
|
$ 19.8 | -7.86 % | $ 150 M | Nasdaq Global Market | ||
|
BioNano Genomics
BNGO
|
$ 1.12 | -6.3 % | $ 6.1 M | Nasdaq Capital Market,SPB | ||
|
Bioventus
BVS
|
$ 10.65 | -6.74 % | $ 710 M | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 670.93 | -3.95 % | $ 54 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 18.63 | -5.34 % | $ 573 M | Nasdaq Global Market | ||
|
CareDx, Inc
CDNA
|
$ 76.31 | -11.13 % | $ 4.07 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Biomerica
BMRA
|
$ 1.61 | -7.2 % | $ 4.69 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 7.0 | 22.38 % | $ 31 M | Nasdaq Global Select Market | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 201.41 | -0.84 % | $ 15.8 B | Nasdaq Global Select Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 0.27 | -24.13 % | $ 359 K | Nasdaq Capital Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 13.26 | 3.35 % | $ 139 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
DarioHealth Corp.
DRIO
|
$ 2.74 | -7.74 % | $ 10.9 M | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
$ 50.87 | 0.11 % | $ 11 B | NYSE | ||
|
Myriad Genetics
MYGN
|
$ 6.29 | 4.49 % | $ 582 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 5.01 | 1.32 % | $ 3.94 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 16.48 | -3.91 % | $ 2.11 B | Nasdaq Global Select Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.75 | -1.41 % | $ 1.31 B | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 2.42 | -4.9 % | $ 726 M | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 11.67 | -6.38 % | $ 2.54 B | Nasdaq Global Select Market,SPB | ||
|
Precipio
PRPO
|
$ 18.57 | -5.11 % | $ 29.8 M | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 15.53 | -1.65 % | $ 1.39 B | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 12.82 | -10.7 % | $ 540 M | Nasdaq Global Select Market,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 154.56 | -8.32 % | $ 19.4 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 25.49 | -5.84 % | $ 571 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.